Intravenous dipyridamole thallium-201 SPECT imaging

Methodology, applications, and interpretations

J. F. Rockett, H. L. Magill, Vivian Loveless, G. L. Murray

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Intravenous dipyridamole Tl-201 testing is an accurate, noninvasive technique for diagnosing coronary artery disease and for risk stratification, particularly in those patients who cannot exercise maximally. The procedure is safe and has a low complication rate, but it should be used with caution in patients who have bronchospastic lung disease or easily induced myocardial ischemia. Theophylline, caffeine, and other methylxanthines can cause false-negative results. We believe that, as the clinical applications of dipyridamole imaging continue to be refined and the population ages, dipyridamole Tl-201 testing, particularly when combined with exercise, will become more commonly used than exercise Tl-201 imaging.

Original languageEnglish (US)
Pages (from-to)712-725
Number of pages14
JournalClinical Nuclear Medicine
Volume15
Issue number10
DOIs
StatePublished - Jan 1 1990
Externally publishedYes

Fingerprint

Dipyridamole
Thallium
Single-Photon Emission-Computed Tomography
Exercise
Theophylline
Caffeine
Lung Diseases
Myocardial Ischemia
Coronary Artery Disease
Population

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

Intravenous dipyridamole thallium-201 SPECT imaging : Methodology, applications, and interpretations. / Rockett, J. F.; Magill, H. L.; Loveless, Vivian; Murray, G. L.

In: Clinical Nuclear Medicine, Vol. 15, No. 10, 01.01.1990, p. 712-725.

Research output: Contribution to journalReview article

@article{8ba12718cb0341f288cd25ba48e44ce0,
title = "Intravenous dipyridamole thallium-201 SPECT imaging: Methodology, applications, and interpretations",
abstract = "Intravenous dipyridamole Tl-201 testing is an accurate, noninvasive technique for diagnosing coronary artery disease and for risk stratification, particularly in those patients who cannot exercise maximally. The procedure is safe and has a low complication rate, but it should be used with caution in patients who have bronchospastic lung disease or easily induced myocardial ischemia. Theophylline, caffeine, and other methylxanthines can cause false-negative results. We believe that, as the clinical applications of dipyridamole imaging continue to be refined and the population ages, dipyridamole Tl-201 testing, particularly when combined with exercise, will become more commonly used than exercise Tl-201 imaging.",
author = "Rockett, {J. F.} and Magill, {H. L.} and Vivian Loveless and Murray, {G. L.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1097/00003072-199010000-00013",
language = "English (US)",
volume = "15",
pages = "712--725",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Intravenous dipyridamole thallium-201 SPECT imaging

T2 - Methodology, applications, and interpretations

AU - Rockett, J. F.

AU - Magill, H. L.

AU - Loveless, Vivian

AU - Murray, G. L.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Intravenous dipyridamole Tl-201 testing is an accurate, noninvasive technique for diagnosing coronary artery disease and for risk stratification, particularly in those patients who cannot exercise maximally. The procedure is safe and has a low complication rate, but it should be used with caution in patients who have bronchospastic lung disease or easily induced myocardial ischemia. Theophylline, caffeine, and other methylxanthines can cause false-negative results. We believe that, as the clinical applications of dipyridamole imaging continue to be refined and the population ages, dipyridamole Tl-201 testing, particularly when combined with exercise, will become more commonly used than exercise Tl-201 imaging.

AB - Intravenous dipyridamole Tl-201 testing is an accurate, noninvasive technique for diagnosing coronary artery disease and for risk stratification, particularly in those patients who cannot exercise maximally. The procedure is safe and has a low complication rate, but it should be used with caution in patients who have bronchospastic lung disease or easily induced myocardial ischemia. Theophylline, caffeine, and other methylxanthines can cause false-negative results. We believe that, as the clinical applications of dipyridamole imaging continue to be refined and the population ages, dipyridamole Tl-201 testing, particularly when combined with exercise, will become more commonly used than exercise Tl-201 imaging.

UR - http://www.scopus.com/inward/record.url?scp=0025089616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025089616&partnerID=8YFLogxK

U2 - 10.1097/00003072-199010000-00013

DO - 10.1097/00003072-199010000-00013

M3 - Review article

VL - 15

SP - 712

EP - 725

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 10

ER -